About NUSHORES BIOSCIENCES LLC
NuShores Biosciences, founded in 2014, commercializes patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company focuses on healing large segmental bone defects using its NuCress™ scaffold technology, which has shown effectiveness in preclinical testing across multiple species.
Development and commercialization of patented bone and tissue regeneration technologiesCreation of NuCress™ scaffold technology for bone regenerationControlled design, shape, and form of scaffoldsShelf-life stability and tolerance over a wide range of storage conditionsTesting in over 500 large test subjects across 8 different species
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NUSHORES DHA SBIR D PH II H2D-0202 CATALYTICALLY ACTIVE DEVICE THAT REMOVES ETHYLENE OXIDE (ETO) USED IN STERI | Department of Defense | $3.0M | |
| DHA SBIR 2ND PH II H2S-0068 MEDICAL RESEARCH AND DEVELOPMENT CONTRACT TITLED PRODUCT DEVELOPMENT AND COMMERCIA | Department of Defense | $1.3M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NUSHORES BIOSCIENCES LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.